Macrogen offers panel screening for major cancers
Macrogen Corp. offers cancer panel screening services to North American research institutions. Cancer panels are highly advanced DNA screenings that identify specific genes and genetic mutations that are related to major cancers. These panels use Next Generation Sequencing technology, which make it possible to process, sequence, and analyze large volumes of genes and long strands of genetic code. With genome sequencing, physicians can individualize treatment plans for a specific patient’s needs.
Benefits of Cancer Panels
Cancer panels examine our complex genetic information and provide extremely detailed and patient-oriented data, regarding the drivers of major cancers. Panels have the potential to uncover advanced genetic diagnoses, and provide prevention strategies and individualized courses of treatments. Macrogen’s cancer panels provide:
- Most accurate diagnoses through Next Generation Sequencing under our CLIA license.
- Analyses based on ACMG*-recommended genes, to offer patients more credible data.
- Coverage of the most major cancers (Breast Cancer, Pancreatic Cancer, Colon Cancer, Ovarian Cancer, Uterine Cancer, Renal Cancer, Endocrine Cancer, Kidney Cancer, Parathyroid Cancer, Brain Cancer, and Eye Cancer)
Our panels use ACMG recommended genes for cancers
Our panel tests major cancers. (Breast Cancer, Pancreatic Cancer, Colon Cancer, Ovarian Cancer, Uterine Cancer, Renal Cancer, Endocrine Cancer, Kidney Cancer, Parathyroid Cancer, Brain Cancer, and Eye Cancer)
* American College of Medical Genetics and Genomics
Contact Us about this service.